Company registration number 01534529 (England and Wales)
COOLING'S NURSERIES LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
COOLING'S NURSERIES LIMITED
COMPANY INFORMATION
Directors
G D Carvosso
I Hazon
A Daly
D A Ross
Company number
01534529
Registered office
Rushmore Hill
Nr Knockholt
Sevenoaks
Kent
TN14 7NN
Auditor
Perrys Audit Limited
Chartered Accountants
4th Floor
399-401 Strand
London
United Kingdom
WC2R 0LT
COOLING'S NURSERIES LIMITED
CONTENTS
Page
Strategic report
1 - 4
Directors' report
5
Directors' responsibilities statement
6
Profit and loss account
7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 24
Independent auditor's report
25 - 27
COOLING'S NURSERIES LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2026
- 1 -
The directors present the strategic report for the year ended 31 January 2026.
Review of the business
The principal activity of the company continues to be the growing of plants and the operation of garden centres, supported by a range of diversification activities that complement these core operations.
The financial year was shaped by several external factors that materially affected trading performance across the Group. Despite these challenges, turnover increased slightly to £11,409,181 (2025: £11,189,753), demonstrating the underlying strength of the Coolings brand and the resilience of our customer base.
Impact of Road Closures
The most significant disruption during the year was the prolonged closure of Rushmore Hill, the main access route serving Coolings Lifestyle and Coolings The Gardener’s Garden Centre. The road was closed from March to mid‑May, and again from early June until the end of September 2026, severely restricting customer access during the peak spring and summer trading periods.
This resulted in reduced footfall, suppressed turnover at both sites, and operational challenges for deliveries and customer flow. The directors consider this to have been a major external event with a clear adverse impact on trading performance.
Weather and Consumer Confidence
Weather patterns also influenced demand throughout the year. April trading benefited from favourable conditions and performed ahead of expectations, but the season ended earlier than usual with a weaker May. The summer period was dominated by hot weather and South East Water hosepipe restrictions, which reduced consumer confidence and discretionary spending on gardening products.
These factors continue to highlight the sector’s dependency on weather patterns and the importance of building resilience through diversification.
Operational Efficiency and Labour Management
Management maintained a strong focus on cost control. Seasonal employment contracts were concluded promptly at the end of peak periods, resulting in lower labour costs without compromising service levels. This contributed positively to operating efficiency during a challenging trading year.
Closure of Hardy Nursery Production
Following a detailed review of the profitability and long‑term viability of Hardy Nursery Production at Rushmore Hill, the decision was taken to cease hardy plant production during the year. This strategic change:
Delivers significant ongoing savings in labour and production costs
Provides greater flexibility in sourcing stock
Improves control over plant availability and production schedules
Resulted in one‑off redundancy costs reflected in administrative expenses
COOLING'S NURSERIES LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 2 -
The directors recognise the cultural significance of this decision. Coolings has grown plants continuously since 1913, and home‑grown production has long been central to the company’s identity. While hardy production has ceased, bedding plant production continues, and management remains committed to developing in this area through continuous improvement, efficiency gains and enhanced productivity.
Diversification of Retail Ranges
The Group continued to broaden its retail proposition beyond traditional horticultural products. Investment in gifting, homeware and lifestyle ranges has strengthened non‑plant sales, improved average basket value, and reduced reliance on seasonal weather patterns. This diversification remains a key part of the Group’s long‑term strategy to create a more balanced and resilient retail business.
Principal risks and uncertainties
The business continues to face several risks common to the wider retail and horticultural sector. The most significant risks identified by the directors for the 2025-2026 financial year are as follows:
Weather Dependency
Seasonal weather conditions remain the most influential factor affecting horticultural demand. The mixed trading pattern experienced during the year demonstrates the volatility of weather‑related sales.
Infrastructure Disruption
The prolonged closure of Rushmore Hill had a material adverse impact on footfall and turnover, highlighting the vulnerability of the business to external infrastructure issues.
Consumer Spending Pressures
The ongoing cost of living challenges continue to constrain discretionary household spending, directly affecting garden related purchases and café restaurant activity.
Rising Operational Costs
Energy, labour and supply chain costs remain elevated. The business continues to monitor and manage these pressures carefully, but they represent a significant ongoing risk to margins.
Energy Price Volatility and Supply Shocks
The company remains exposed to fluctuations in energy pricing, which can materially affect operating costs. Global supply uncertainty and market volatility continue to pose risks to both cost stability and long‑term planning.
Government Legislation and Regulatory Changes
Uncertainty surrounding government policy including changes to the National Living Wage (NLW), National Insurance (NI), and wider business taxation presents a significant risk to cost forecasting and long term financial planning. Any increases in statutory employment costs have a direct impact on profitability, particularly in a our labour intensive retail and horticultural environment.
Plant health regulations also continue to evolve, increasing administrative requirements and compliance costs, although optimistically this legislation may get easier with ongoing realignment with the EU.
Supply Chain and Production Risks
Following the closure of Hardy Nursery Production, the business is more reliant on external growers for hardy stock. While this provides greater flexibility, it also introduces risks relating to supplier availability, quality consistency and pricing.
COOLING'S NURSERIES LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
Development and performance
The year saw significant operational and strategic developments:
Completion of the review and closure of Hardy Nursery Production
Continued strengthening of bedding plant production
Improved labour efficiency through seasonal contract management
Expansion of non plant retail categories
Ongoing investment in customer experience and retail standards
Continued engagement with the Employee Ownership Trust (EOT)
The directors remain confident that these changes will strengthen the business and improve long‑term profitability.
Key performance indicators
| | | |
| | | Slight increase despite major road closures; strong April trading. |
| | | Improved purchasing discipline and margin management. |
| | | Reduced due to road closures and one‑off redundancy costs. |
| | | Lower due to reduced operating cash flow and EOT repayments. |
| | | Reflects restructuring of nursery operations and overall review of labour structures. |
COOLING'S NURSERIES LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 4 -
Future Outlook
Looking ahead, the directors anticipate a more stable trading environment once normal access to Rushmore Hill resumes. The operational changes implemented during the year particularly the restructuring of nursery production and improved labour efficiency have strengthened the business and reduced fixed costs.
The company will continue to:
Develop and review existing bedding plant production
Enhance non‑plant retail ranges
Improve operational efficiency
Manage costs carefully
Strengthen resilience against weather‑driven volatility
The directors remain confident that Coolings is well positioned to navigate future economic and environmental challenges, supported by a clear strategic direction, a loyal customer base, and a committed team.
D A Ross
Director
29 July 2026
COOLING'S NURSERIES LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JANUARY 2026
- 5 -
The directors present their annual report and financial statements for the year ended 31 January 2026.
Principal activities
The principal activity of the company in the year under review was that of growing, cultivation and retail of plants and garden products.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £16,667. The directors do not recommend payment of a further dividend.
No preference dividends were paid.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
G D Carvosso
I Hazon
A Daly
D A Ross
Auditor
Perrys Audit Limited were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
D A Ross
Director
29 July 2026
COOLING'S NURSERIES LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 JANUARY 2026
- 6 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
COOLING'S NURSERIES LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 JANUARY 2026
- 7 -
2026
2025
Notes
£
£
Turnover
3
11,409,181
11,189,753
Cost of sales
(5,444,148)
(5,398,320)
Gross profit
5,965,033
5,791,433
Administrative expenses
(6,088,117)
(5,736,093)
Other operating income
276,795
264,546
Operating profit
4
153,711
319,886
Interest receivable and similar income
7
31,238
63,467
Profit before taxation
184,949
383,353
Tax on profit
8
(121,292)
(164,765)
Profit for the financial year
63,657
218,588
The profit and loss account has been prepared on the basis that all operations are continuing operations.
COOLING'S NURSERIES LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JANUARY 2026
- 8 -
2026
2025
£
£
Profit for the year
63,657
218,588
Other comprehensive income
-
-
Total comprehensive income for the year
63,657
218,588
COOLING'S NURSERIES LIMITED (REGISTERED NUMBER: 01534529)
BALANCE SHEET
AS AT 31 JANUARY 2026
31 January 2026
- 9 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
11
2,472,523
2,646,695
Current assets
Stocks
12
2,376,987
2,372,392
Debtors
13
363,988
450,920
Cash at bank and in hand
711,055
1,336,550
3,452,030
4,159,862
Creditors: amounts falling due within one year
14
(1,364,017)
(1,938,539)
Net current assets
2,088,013
2,221,323
Total assets less current liabilities
4,560,536
4,868,018
Provisions for liabilities
Deferred tax liability
15
268,750
271,356
(268,750)
(271,356)
Net assets
4,291,786
4,596,662
Capital and reserves
Called up share capital
17
1,002
1,002
Profit and loss reserves
4,290,784
4,595,660
Total equity
4,291,786
4,596,662
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 29 July 2026 and are signed on its behalf by:
D A Ross
Director
COOLING'S NURSERIES LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2026
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 February 2024
1,002
5,140,774
5,141,776
Year ended 31 January 2025:
Profit and total comprehensive income for the year
-
218,588
218,588
Dividends
9
-
(25,000)
(25,000)
Contributions to EOT
-
(622,775)
(622,775)
Balance at 31 January 2025
1,002
4,595,660
4,596,662
Year ended 31 January 2026:
Profit and total comprehensive income for the year
-
63,657
63,657
Dividends
9
-
(16,667)
(16,667)
Contributions to EOT
-
(351,865)
(351,865)
Balance at 31 January 2026
1,002
4,290,784
4,291,786
COOLING'S NURSERIES LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2026
- 11 -
2026
2025
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
22
172,406
1,019,580
Income taxes paid
(178,051)
(294,532)
Net cash (outflow)/inflow from operating activities
(5,645)
725,048
Investing activities
Purchase of tangible fixed assets
(282,556)
(269,427)
Proceeds on disposal of tangible fixed assets
7,500
Interest received
31,238
63,467
Net cash used in investing activities
(251,318)
(198,460)
Financing activities
Contributions to EOT
(351,865)
(738,702)
Dividends paid
(16,667)
(25,000)
Net cash used in financing activities
(368,532)
(763,702)
Net decrease in cash and cash equivalents
(625,495)
(237,114)
Cash and cash equivalents at beginning of year
1,336,550
1,573,664
Cash and cash equivalents at end of year
711,055
1,336,550
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 12 -
1
Accounting policies
Company information
Cooling's Nurseries Limited is a private company limited by shares incorporated in England and Wales. The registered office is Rushmore Hill, Nr Knockholt, Sevenoaks, Kent, TN14 7NN.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
The company recognises revenue on goods sold at the point of sale through its shop tills. Revenue in respect of commissions and services rendered is recognised when performance has been fulfilled.
1.4
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 5 years.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings/lease improvements
See below
Plant and equipment
Over the term of the lease or 20% reducing balance
Fixtures and fittings
20% reducing balance
Motor vehicles
20% straight line
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 13 -
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Freehold land is not depreciated. Freehold buildings are depreciated over 10 years.
In the year, depreciation for motor vehicles has changed from 25% reducing balance to 20% straight line based on the NBV as at 31/01/2025.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Cost is determined using a weighted average cost formula.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 14 -
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 15 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
As lessor
When the company acts as a lessor, a lease is classified as a finance lease whenever it transfers substantially all the risks and rewards of ownership of the underlying asset to the lessee, either at the end of the lease term or for the major part of the economic life of the asset. All other leases are classified as operating leases. If an arrangement contains both lease and non-lease components, the company allocates the consideration in the contract to the two elements.
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 16 -
Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
A key example of such an estimate is with regard to the company making provision for replacement goods under its hardy plant guarantee.
3
Turnover and other revenue
2026
2025
£
£
Turnover analysed by class of business
Sale of goods
11,093,631
10,881,162
Rendering of services
102,870
110,237
Commissions received
212,680
198,354
11,409,181
11,189,753
2026
2025
£
£
Turnover analysed by geographical market
UK
11,409,181
11,189,753
2026
2025
£
£
Other revenue
Interest income
31,238
63,467
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 17 -
4
Operating profit
2026
2025
Operating profit for the year is stated after charging/(crediting):
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
16,620
15,000
Depreciation of tangible fixed assets
456,728
408,224
Profit on disposal of tangible fixed assets
-
(1,104)
Amortisation of intangible assets
-
24,999
Operating lease charges
135,892
135,720
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2026
2025
Number
Number
Production and sales
158
159
administration and support
28
28
Total
186
187
Their aggregate remuneration comprised:
2026
2025
£
£
Wages and salaries
3,501,944
3,328,756
Social security costs
321,928
241,253
Pension costs
157,002
134,834
3,980,874
3,704,843
6
Directors' remuneration
2026
2025
£
£
Remuneration for qualifying services
285,446
278,894
Company pension contributions to defined contribution schemes
41,043
62,302
326,489
341,196
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 4 (2025 - 4).
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
6
Directors' remuneration
(Continued)
- 18 -
Remuneration disclosed above include the following amounts paid to the highest paid director:
2026
2025
£
£
Remuneration for qualifying services
116,163
110,135
Company pension contributions to defined contribution schemes
12,833
28,683
7
Interest receivable and similar income
2026
2025
£
£
Interest income
Interest on bank deposits
31,238
63,467
8
Taxation
2026
2025
£
£
Current tax
UK corporation tax on profits for the current period
123,898
178,051
Deferred tax
Origination and reversal of timing differences
(2,606)
(13,286)
Total tax charge
121,292
164,765
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2026
2025
£
£
Profit before taxation
184,949
383,353
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2025: 25.00%)
46,237
95,838
Gains not taxable
(276)
Permanent capital allowances in excess of depreciation
77,661
82,489
Deferred tax
(2,606)
(13,286)
Taxation charge for the year
121,292
164,765
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 19 -
9
Dividends
2026
2025
£
£
Final paid
16,667
25,000
10
Intangible fixed assets
Goodwill
£
Cost
At 1 February 2025 and 31 January 2026
725,000
Amortisation and impairment
At 1 February 2025 and 31 January 2026
725,000
Carrying amount
At 31 January 2026
At 31 January 2025
Goodwill is purchased goodwill in relation to the acquisition of two garden centres, the first in
November 2017 and the second in June 2019. The amortisation expense for the year is included in administrative expenses.
On 31 July 2020, the company purchased the trade and assets of the nursery known as Coolings Green & Pleasant (now Coolings Lifestyle), which was controlled by the director, P M Cooling. All assets were acquired at fair value including leasehold property improvements (£1), plant and machinery (£60,000), stock (£197,191) and goodwill (£nil).
11
Tangible fixed assets
Freehold land and buildings/lease improvements
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 February 2025
5,416,427
747,057
1,722,459
380,955
8,266,898
Additions
191,269
27,833
63,454
282,556
At 31 January 2026
5,607,696
747,057
1,750,292
444,409
8,549,454
Depreciation and impairment
At 1 February 2025
3,488,139
480,229
1,457,368
194,467
5,620,203
Depreciation charged in the year
239,585
23,978
90,403
102,762
456,728
At 31 January 2026
3,727,724
504,207
1,547,771
297,229
6,076,931
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
11
Tangible fixed assets
Freehold land and buildings/lease improvements
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
(Continued)
- 20 -
Carrying amount
At 31 January 2026
1,879,972
242,850
202,521
147,180
2,472,523
At 31 January 2025
1,928,288
266,828
265,091
186,488
2,646,695
Included in the £1,907m above is freehold land and buildings of £1,014m (2024: £1,030m).
12
Stocks
2026
2025
£
£
Finished goods and goods for resale
2,376,987
2,372,392
13
Debtors
2026
2025
Amounts falling due within one year:
£
£
Other debtors
174,028
170,413
Prepayments and accrued income
189,960
280,507
363,988
450,920
14
Creditors: amounts falling due within one year
2026
2025
Notes
£
£
Trade creditors
839,503
874,549
Corporation tax
123,898
178,051
Other taxation and social security
176,329
123,883
Deferred income
61,388
Other creditors
129,437
715,717
Accruals and deferred income
33,462
46,339
1,364,017
1,938,539
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 21 -
15
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2026
2025
Balances:
£
£
Accelerated capital allowances
268,750
271,356
2026
Movements in the year:
£
Liability at 1 February 2025
271,356
Credit to profit or loss
(2,606)
Liability at 31 January 2026
268,750
16
Retirement benefit schemes
2026
2025
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
157,002
134,834
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
17
Share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
750
750
750
750
Cooling family ordinary of £1 each
250
250
250
250
1,000
1,000
1,000
1,000
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
17
Share capital
(Continued)
- 22 -
2026
2025
2026
2025
Preference share capital
Number
Number
£
£
Issued and fully paid
Preference shares of £1 each
2
2
2
2
Preference shares classified as equity
2
2
Total equity share capital
1,002
1,002
Ordinary shares have the following rights, preferences and restrictions:
The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the company.
Preference shares hold no voting rights and have no dividend rights.
Rights of shareholders on a return of capital or otherwise - 1st paying the EOT its entitlement, 2nd preference shares and 3rd distributed equally amongst other holders of Ordinary shares and Cooling Family Ordinary shares.
18
Financial commitments, guarantees and contingent liabilities
Fixed and floating charges are held over the company's assets by two of the shareholders of this company. The charge held is in relation to security for sum owed under a share purchase agreement.
Prior to the 2022-2023 financial year an Employee Ownership Trust (EOT) was created which purchased shares from the shareholders at that time.
As at the balance sheet date, the remaining EOT balance outstanding was £1,867,030. This is anticipated to be paid by February 2032.
During the year the amounts paid under the EOT amounted to £351,865 including interest (2025: £738,703).
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 23 -
19
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2026
2025
£
£
Within one year
134,000
134,000
Between two and five years
139,500
269,333
273,500
403,333
Lessor
2026
2025
£
£
Within one year
252,313
199,845
Between two and five years
247,006
272,458
499,319
472,303
The amount of non-cancellable operating lease payments recognised as an expense during the year was £134,000 (2025: £134,000).
20
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
Rent payable
2026
2025
£
£
Other related parties
84,000
84,000
Details of the acquisition of the nursery known as Coolings Green & Pleasant, are provided in note 10.
21
Ultimate controlling party
Cooling's Nurseries EOT Trustees Limited is the ultimate controlling party.
COOLING'S NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 24 -
22
Cash generated from operations
2026
2025
£
£
Profit after taxation
63,657
218,588
Adjustments for:
Taxation charged
121,292
164,765
Investment income
(31,238)
(63,467)
Gain on disposal of tangible fixed assets
-
(1,104)
Amortisation and impairment of intangible assets
24,999
Depreciation and impairment of tangible fixed assets
456,728
408,224
Movements in working capital:
(Increase)/decrease in stocks
(4,595)
24,590
Decrease/(increase) in debtors
86,932
(33,483)
(Decrease)/increase in creditors
(581,758)
276,468
Increase in deferred income
61,388
-
Cash generated from operations
172,406
1,019,580
23
Analysis of changes in net funds
1 February 2025
Cash flows
31 January 2026
£
£
£
Cash at bank and in hand
1,336,550
(625,495)
711,055
COOLING'S NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF COOLING'S NURSERIES LIMITED
- 25 -
Opinion
We have audited the financial statements of Cooling's Nurseries Limited (the 'company') for the year ended 31 January 2026 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 January 2026 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
COOLING'S NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF COOLING'S NURSERIES LIMITED (CONTINUED)
- 26 -
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
COOLING'S NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF COOLING'S NURSERIES LIMITED (CONTINUED)
- 27 -
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates, and considered the risk of acts by the company that were contrary to applicable laws and regulations, including fraud.
We designed audit procedures to respond to the risk, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.
We focused on laws and regulations which could give rise to a material misstatement in the financial statements, including, but not limited to, the Companies Act 2006 and UK tax legislation. Our tests included agreeing the financial statement disclosures to underlying supporting documentation and enquiries with management.
We did not identify any key audit matters relating to irregularities, including fraud. As in all our audits, we also addressed the risk of management override of internal controls, including testing journals and evaluating whether there was evidence of bias by the directors that represented a risk of material misstatement due to fraud.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Declan McCusker (Senior Statutory Auditor)
For and on behalf of Perrys Audit Limited, Statutory Auditor
Chartered Accountants
4th Floor
399-401 Strand
London
WC2R 0LT
United Kingdom
1 September 2026
2026-01-312025-02-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.200G D CarvossoI HazonA DalyD A Ross015345292025-02-012026-01-3101534529bus:Director12025-02-012026-01-3101534529bus:Director22025-02-012026-01-3101534529bus:Director32025-02-012026-01-3101534529bus:Director42025-02-012026-01-3101534529bus:RegisteredOffice2025-02-012026-01-31015345292026-01-31015345292024-02-012025-01-3101534529core:RetainedEarningsAccumulatedLosses2024-02-012025-01-3101534529core:RetainedEarningsAccumulatedLosses2025-02-012026-01-31015345292025-01-3101534529core:WithinOneYear2026-01-3101534529core:WithinOneYear2025-01-3101534529core:CurrentFinancialInstrumentscore:WithinOneYear2026-01-3101534529core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3101534529core:ShareCapital2026-01-3101534529core:ShareCapital2025-01-3101534529core:RetainedEarningsAccumulatedLosses2026-01-3101534529core:RetainedEarningsAccumulatedLosses2025-01-3101534529core:ShareCapital2024-01-3101534529core:ShareCapitalOrdinaryShareClass12026-01-3101534529core:ShareCapitalOrdinaryShareClass12025-01-3101534529core:ShareCapitalOrdinaryShareClass22026-01-3101534529core:ShareCapitalOrdinaryShareClass22025-01-3101534529core:ShareCapitalOrdinaryShares2026-01-3101534529core:ShareCapitalOrdinaryShares2025-01-3101534529core:ShareCapitalPreferenceShareClass12026-01-3101534529core:ShareCapitalPreferenceShareClass12025-01-31015345292025-01-31015345292024-01-3101534529core:Goodwill2025-02-012026-01-3101534529core:LandBuildingscore:OwnedOrFreeholdAssets2025-02-012026-01-3101534529core:PlantMachinery2025-02-012026-01-3101534529core:FurnitureFittings2025-02-012026-01-3101534529core:MotorVehicles2025-02-012026-01-3101534529core:UKTax2025-02-012026-01-3101534529core:UKTax2024-02-012025-01-310153452912025-02-012026-01-310153452912024-02-012025-01-310153452922025-02-012026-01-310153452922024-02-012025-01-3101534529core:Goodwill2025-01-3101534529core:Goodwill2026-01-3101534529core:Goodwill2025-01-3101534529core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-3101534529core:PlantMachinery2025-01-3101534529core:FurnitureFittings2025-01-3101534529core:MotorVehicles2025-01-3101534529core:LandBuildingscore:OwnedOrFreeholdAssets2026-01-3101534529core:PlantMachinery2026-01-3101534529core:FurnitureFittings2026-01-3101534529core:MotorVehicles2026-01-3101534529core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-3101534529core:PlantMachinery2025-01-3101534529core:FurnitureFittings2025-01-3101534529core:MotorVehicles2025-01-3101534529core:CurrentFinancialInstruments2026-01-3101534529core:CurrentFinancialInstruments2025-01-3101534529bus:OrdinaryShareClass12025-02-012026-01-3101534529bus:OrdinaryShareClass22025-02-012026-01-3101534529bus:PreferenceShareClass12025-02-012026-01-3101534529bus:OrdinaryShareClass12026-01-3101534529bus:OrdinaryShareClass12025-01-3101534529bus:OrdinaryShareClass22026-01-3101534529bus:OrdinaryShareClass22025-01-3101534529bus:AllOrdinaryShares2026-01-3101534529bus:AllOrdinaryShares2025-01-3101534529bus:PreferenceShareClass12026-01-3101534529bus:PreferenceShareClass12025-01-3101534529core:BetweenTwoFiveYears2026-01-3101534529core:BetweenTwoFiveYears2025-01-3101534529bus:PrivateLimitedCompanyLtd2025-02-012026-01-3101534529bus:FRS1022025-02-012026-01-3101534529bus:Audited2025-02-012026-01-3101534529bus:FullAccounts2025-02-012026-01-31xbrli:purexbrli:sharesiso4217:GBP